Chapter 3.1 Flashcards
- Describe the joint changes characteristic of osteoarthritis
progressive wear and tear of large joints. Hypertrophy and spurring of bone and erosion of cartilage
- List the categories of drugs used in the management of osteoarthritis.
analgesics and joint protection and restoration
- Indicate the stage of osteoarthritis that is best managed by acetaminophen and NSAIDs.
Early to mod stages for acetaminophen
NSAID’s: any stage of OA
- List the advantages and disadvantages of the categories of drugs used in the management of osteoarthritis.
Acetaminophen is easier on stomach and anti-inflammatory effects not needed
NSAID’s are more helpful in later stages if synovitis develops
- Define viscosupplementation.
try to supplement the viscous property of joint fluids. Helps restore the viscosity of synovial fluid and keeps joint better lubricated. Done by injecting hyaluronan into joint
- State the mechanism of action of glucosamine and chondroitin sulfate in the management of osteoarthritis.
Provide substrates to help regenerate and maintain strength of cartilage and synovial fluid
- Describe the joint changes characteristic of rheumatoid arthritis
pain, stiffness, inflammation and damage in various joints
- State the role of autoimmunity in the development of rheumatoid arthritis using the terms systemic and synovial inflammation, tumor necrosis factor-alpha, and interleukins.
Immune system goes haywire and does this via chemical and cellular factors like tumor necrosis, factor alpha or interleukin 1 or 6.
- Indicate the role of the following agents in the management of rheumatoid arthritis: acetaminophen, NSAIDs
NSAID’s are the cornerstone of treatment in RA and are good at treating mild inflammation and pain.
glucocorticoids
are powerful inflammatory supressents. These drugs are great after a flare up. Huge side effects doe
and disease-modifying anti-rheumatic drugs (DMARDS)
modifying the course of RA and try to slow it down.
- State the mechanism of action of the traditional DMARDs.
inhibit the autoimmune response underlying RA. Inhibit cytokine synthesis or inhibit cellular activation of monocytes, T and B lymphocytes
- State the mechanism of action of tumor necrosis factor inhibitors
Suppresses a specific messenger that promotes the immune response called TNF-alpha.
- State the mechanism of action of anakinra.
blocks effects of interleukin 1 on joint tissues. It spars immune functions
- Indicate the therapeutic categories of the following agents: ibuprofen
NSAID